MTOR and Iron deficiency anemia: Przybylowski et al. reported elevated hepcidin and IL-6 levels in orthotopic heart transplant patients treated with mTOR inhibitors and suggested that chronic inflammation and increased hepcidin production may be responsible for functional iron deficiency in these patients (29).